The post KindlyMD (NAKA) faces Nasdaq delisting risk after shares trade below $1 for 30 straight days appeared on BitcoinEthereumNews.com. Kindly MD (NAKA), a healthThe post KindlyMD (NAKA) faces Nasdaq delisting risk after shares trade below $1 for 30 straight days appeared on BitcoinEthereumNews.com. Kindly MD (NAKA), a health

KindlyMD (NAKA) faces Nasdaq delisting risk after shares trade below $1 for 30 straight days

Kindly MD (NAKA), a health-care and bitcoin treasury company company, faces being delisted from the Nasdaq exchange after its share price failed to meet minimum listing requirements.

The stock has closed below $1 for 30 consecutive trading days, and the company has until June 8 to lift it above that level for 10 straight days to avoid the delisting, it said in an SEC filing on Dec. 12.

The company was bought in a reverse takeover by Nakomoto in August, which kept the KindlyMD name and changed the stock ticker. It owns 5,398 BTC ($466 million) and is the 19th largest corporate holder of bitcoin, according to the BitcoinTreasuries.net.

The shares, which surged to a record in May when the deal was announced, have since slumped 99% and closed Monday at 38 cents, a 0.817 multiple of the net asset value (mNAV).

If the shares don’t meet the listing requirement by June, there are still avenues open. Nasdaq may grant an extension, the company could potentially address the issue through a reverse stock split or it may apply to transfer to the Nasdaq Capital Market.

Read more: KindlyMD Turns to Kraken as Fourth Provider for Bitcoin-Backed $210M Loan at 8%

Source: https://www.coindesk.com/markets/2025/12/16/kindlymd-faces-nasdaq-delisting-risk-after-failing-to-meet-minimum-share-price-levels

Market Opportunity
Nakamoto Games Logo
Nakamoto Games Price(NAKA)
$0.07882
$0.07882$0.07882
-0.58%
USD
Nakamoto Games (NAKA) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.